Form 4: Stryker Corp Executive Becker Exercises Stock Options and Disposes of Shares

Yin C. Becker, VP and Chief Corporate Affairs Officer at Stryker Corp, exercised stock options and disposed of shares on November 5, 2024.

Summary

• On November 5, 2024, Yin C. Becker, VP and Chief Corporate Affairs Officer of Stryker Corp, executed transactions involving Stryker's common stock.
• Becker exercised employee stock options to acquire 4,980 shares at a price of $96.64 per share.
• Following the exercise, Becker disposed of 3,189 shares at a price of $366.9.
• After these transactions, Becker directly owns 30,749 shares of common stock and indirectly owns 2,377 shares through a 401K.
• Becker also continues to hold 4,980 derivative securities in the form of employee stock options.

Sentiment

Score: 5

Explanation: The document is a neutral report of insider trading activity, with no inherent positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the trading activities of Stryker's executives. It is a standard practice for company officers to exercise stock options and manage their holdings.

Comparison to Industry Standards

• Executive compensation practices, including stock options, are common across the medical device industry.
• Companies like Medtronic, Johnson & Johnson, and Boston Scientific also utilize stock options as part of their executive compensation packages.
• The vesting schedules and exercise prices are typically aligned with industry norms to incentivize long-term performance.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely negligible.

Key Dates